Moderna Vaccine Approval - Search News

News

FDA expands approval of Moderna's RSV vaccine

ABC News on MSN · 1d

FDA expands approval of Moderna's RSV vaccine to some adults under age 60

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

USA TODAY · 1d

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.

Reuters on MSN · 1d

US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a lower group of adults aged 18 to 59 years at increased risk for disease. Moderna's RSV shot,

1don MSN

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

1don MSN

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...

2don MSN

Is it Time to Dump Your Shares of Moderna?

After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...

‘People inside Moderna are afraid’: As anti-vaccine climate intensifies, the company has much to lose

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results